Nitric oxide synthase inhibition delays axonal degeneration and promotes the survival of axotomized retinal ganglion cells

Experimental Neurology

Volumn 158, Issue 2, 1999, Pages 366-381

  Koeberle, Paulo D ^a   Ball, Alexander K ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Axotomy; CNOS; INOS; Neurodegeneration; Nitric oxide; NOS inhibitor; Retina; Retinal ganglion cell

Indexed keywords

N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; ENZYME INHIBITION; FEMALE; MICROGLIA; MUELLER CELL; NERVE FIBER DEGENERATION; NERVE FIBER TRANSECTION; NERVOUS SYSTEM INJURY; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL;

EID: 0032816287     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7113     Document Type: Article

References (77)

1. Aloisi F., Care A., Borsllino G., Gallo P., Rosa S., Bassani A., Cabibbo A., Testa U., Levi G., Peschle C. Production of hemolymphopoietic cytokines IL-6, IL-8, colony-stimulating factors by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J. Immunol. 149:1992;2358-2366.
2. Alagarsamy S., DeWitt D. S., Johnson K. M. Effects of moderate, central fluid percussion traumatic brain injury on nitric oxide synthase activity in rats. J. Neurotrauma. 15:1998;627-633.
3. Andersson P. B., Perry V. H., Gordon S. The accute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience. 48:1992;169-186.
4. Benveniste E. N., Kwon J., Chung W. J., Sampson J., Pandya K., Tang L. P. Differential modulation of astrocyte cytokine gene expression by TGF-beta. J. Immunol. 153:1994;5210-5221.
5. Berkelaar M., Clarke D. B., Wang Y. C., Bray G. M., Aguayo A. J. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J. Neurosci. 14:1994;4368-4374.
6. Bohme G. A., Bon C., Stutzmann J. M., Doble A., Blanchard J. C. Possible involvement of nitric oxide in long-term potentiation. Eur. J. Pharmacol. 199:1991;379-381.
7. Bonne C., Muller A., Villain M. Free radicals in retinal ischemia. Gen. Pharmacol. 30:1998;275-280.
8. Bouldin T. W., Cavanagh J. B. Organophosphorus neuropathy. I. A teased-fiber study of the spatio-temporal spread of axonal degeneration. Am. J. Pathol. 94:1979;241-252.
9. Brosnan C. F., Battistini L., Raine C. S., Dickson D. W., Casadevall A., Lee S. C. Reactive nitrogen intermediates in human neuropathology: An overview. Dev. Neurosci. 16:1994;152-161.
10. Bruno V., Scapagnini U., Canonico. Excitatory amino acids and neurotoxicity. Funct. Neurol. 8:1993;279-292.
11. Calka J., Wolf G., Schmidt W. Induction of cytosolic NADPH-diaphorase/nitric oxide synthase in reactive microglia/macrophages after quinolinic acid lesions in the rat striatum: An electron and light microscopical study. Histochem. Cell Biol. 105:1996;81-89.
12. Chao C. C., Hu S., Sheng W. S., Bu D., Bukrinsky M. I., Peterson P. K. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia. 16:1996;276-284.
13. Chao C. C., Hu S., Sheng W. S., Tsang M., Peterson P. K. Tumor necrosis factor-alpha mediates the release of bioactive transforming growth factor-beta in murine microglial cell cultures. Clin. Immunol. Immunopathol. 77:1995;358-365.
14. Chung I. Y., Benveniste E. N. Tumor necrosis factor-alpha production by astrocytes: Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J. Immunol. 144:1990;2999-3007.
15. Cruz T., Gaspar R., Donato A., Lopes C. Interaction between polyalkylcyanoacrylate nanoparticles and peritoneal macrophages: MTT metabolism, NBT reduction, and NO production. Pharmaceut. Res. 14:1997;73-79.
16. Dawson V. L., Brahmbhatt H. P., Mong J. A., Dawson T. M. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures. Neuropharmacology. 33:1994;1425-1430.
17. Dawson V. L., Dawson T. M., London E. D., Bredt D. S., Snyder S. H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA. 88:1991;6368-6371.
18. Dawson V. L., Dawson T. M. Nitric oxide neurotoxicity. J. Chem. Neuroanat. 10:1996;179-190.
19. De Waal Malefyt R., Figdor C. G., Huijbens R., Mohan-Peterson S., Bennett B., Culpepper J., Dang W., Zurawski G., de Vries J. E. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocyte: Comparison with IL-4 and modulation by IFN-gamma or IL-10. J. Immunol. 151:1993;6370-6381.
20. Ding A., Nathan C. F., Graycar J., Derynck R., Stuehr D. J., Srimal S. Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J. Immunol. 145:1990;940-944.
21. Ding M., St B. A., Parkinson J. F., Medberry P., Wong J. L., Rogers N. E., Ignarro L. J., Merrill J. E. Inducible nitric-oxide synthase and nitric oxide production in human fetal astrocytes and microglia: A kinetic analysis. J. Biol. Chem. 272:1997;11327-11335.
22. Endoh M., Maiese K., Wagner. Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia. Brain Res. 651:1994;92-100.
23. Erroi A., Sironi M., Chiaffarino F., Chen Z. G., Mengozzi M., Mantovani A. IL-1 and IL-6 release by tumor-associated macrophages from human ovarian carcinoma. Int. J. Cancer. 44:1989;795-801.
24. Fischer H. G., Nitzgen B., Reichmann G., Hadding U. Cytokine responses induced by Toxoplasma gondii in astrocytes and microglial cells. Eur. J. Immunol. 27:1997;1539-1548.
25. Frey C., Narayanan K., McMillan K., Spack L., Gross S. S., Masters B. S., Griffith O. W. l-Thiocitrulline: A stereospecific, heme-binding inhibitor of nitric oxide synthases. J. Biol. Chem. 269:1994;26083-26091.
26. Gao H., Qiao X., Hefti F., Hollyfield J. G., Knusel B. Elevated mRNA expression of brain derived neurotrophic factor in retinal ganglion cell layer after optic nerve injury. Invest. Ophthalmol. Vis. Sci. 38:1997;1840-1847.
27. Garcia-Valenzuela E., Gorczyca W., Darzynkiewicz Z., Sharma S. C. Apoptosis in adult retinal ganglion cells after axotomy. J. Neurobiol. 25:1994;431-438.
28. Geyer O., Almog J., Lupu-Meiri M., Lazar M., Oron Y. Nitric oxide synthase inhibitors protect rat retina against ischemic injury. FEBS Lett. 374:1995;399-402.
29. Gordon-Weeks P., Gabella G. Degeneration of varicose axons and their phagocytosis by smooth muscle cells. J. Neurocytol. 6:1997;711-721.
30. Haley J. E., Wilcox G. L., Chapman P. F. The role of nitric oxide in hippocampal long-term potentiation. Neuron. 8:1992;211-216.
31. Hellendall R. P., Ting J. P. Differential regulation of cytokine-induced major histocompatibility complex class II expression and nitric oxide release in rat microglia and astrocytes by effectors of tyrosine kinase, protein kinase C and cAMP. J. Neuroimmunol. 74:1997;1997.
32. Hruby Z., Beck K. F. Cytotoxic effect of autocrine and macrophage-derived nitric oxide on cultured rat mesangial cells. Clin. Exp. Immunol. 107:1997;76-82.
33. Huxlin K. R., Bennett M. R. NADPH diaphorase expression in the rat retina after axotomy - A supportive role for nitric oxide. Eur. J. Neurosci. 7:1995;2226-2239.
34. Jacquemin E., de Kozak Y., Thillaye B., Courtois Y., Goureau O. Expression of inducible nitric oxide synthase in the eye from endotoxin-induced uveitis rats. Invest. Ophthalmol. Vis. Sci. 37:1996;1187-1196.
35. Jelsma T. N., Friedman H. H., Berkelaar M., Bray G. M., Aguayo A. J. Different forms of the neurotrophin receptor trkB mRNA predominate in the rat retina and optic nerve. J. Neurobiol. 24:1993;1207-1214.
36. Klocker N., Cellerino A., Bahr M. Free radical scavenging and inhibition of nitric oxide synthase potentiates the neurotrophic effects of brain-derived neurotrophic factor on axotomized retinal ganglion cells in vivo. J. Neurosci. 18:1998;1038-1046.
37. Koeberle P. D., Ball A. K. Effects of GDNF on retinal ganglion cell survival following axotomy. Vis. Res. 38:1998;1505-1515.
38. Kong L. Y., Lai C., Wilson B. C., Simpson J. N., Hong J. S. Protein tyrosine kinase inhibitors decrease lipopolysaccharide-induced proinflammatory cytokine protein in mixed glia, microglia-enriched or astrocyte-enriched cultures. Neurochem. Int. 30:1997;491-497.
39. Lam T. T., Tso M. O. Nitric oxide synthase NOS inhibitors ameliorate retinal damage induced by ischemia in rats. Res. Commun. Mol. Pathol. Pharmacol. 92:1996;329-340.
40. Lau K. C., So K. F., Tay D., Leung M. NADPH-diaphorase neurons in the retina of the hamster. J. Comp. Neurol. 350:1994;550-558.
41. Lee S. C., Liu W., Dickson D. W., Brosnan C. F., Berman J. W. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J. Immunol. 150:1993;2659-2667.
42. Lei S. Z., Pan Z. H., Aggarwal S. K., Chen H. S., Hartman J., Sucher N. J., Lipton S. A. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron. 8:1992;1087-1099.
43. Liu J., Zhao M. L., Brosnan C. F., Lee S. C. Expression of type II nitric oxide synthase in primary human astrocytes and microglia: role of IL-1 beta and IL-1 receptor antagonist. J. Immunol. 157:1996;3569-3576.
44. Lipton S. A., Choi Y. B., Pan Z. H., Lei S. Z., Chen H. S., Sucher N. J., Loscalzo J., Singel D. J., Stamler J. S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626-632.
45. Lucius R., Sievers J. Postnatal retinal ganglion cells in vitro: Protection against reactive oxygen species ROS-induced axonal degeneration by cocultured astrocytes. Brain Res. 743:1996;56-62.
46. Lumme A., Vanhatalo S., Sadeniemi M., Soinila S. Expression of nitric oxide synthase in hypothalamic nuclei following axonal injury or colchicine treatment. Exp. Neurol. 144:1997;248-257.
47. Luth H. J., Arendt T. Co-expression of APP with cNOS but not iNOS after cortical injury in the rat. NeuroReport. 8:1997;2321-2324.
48. Mansour-Robaey S., Clarke D. B., Wang Y. C., Bray G. M., Aguayo A. J. Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc. Natl. Acad. Sci. USA. 91:1994;1632-1636.
49. Manzoni O., Prezeau L., Marin P., Deshager S., Bockaert J., Fagni L. Nitric oxide-induced blockade of NMDA receptors. Neuron. 8:1992;653-662.
50. Mayer B., John M., Heinzel B., Werner E. R., Wachter H., Schultz G., Bohme E. Brain nitric oxide synthase is a biopterin- and flavin-containing multi-functional oxido-reductase. FEBS Lett. 288:1991;187-191.
51. Mayer B., Wu C., Gorren A. C., Pfeiffer S., Schmidt K., Clark P., Stuehr D. J., Werner E. R. Tetrahydrobiopterin binding to macrophage inducible nitric oxide synthase: Heme spin shift and dimer stabilization by the potent pterin antagonist 4-amino-tetrahydrobiopterin. Biochemistry. 36:1997;8422-8427.
52. Minghetti L., Levi G. Microglia as effector cell in brain damage and repair: Focus on prostanoids and nitric oxide. Progressive Neurobiol. 54:1998;99-125.
53. 6-1-Iminoethyl-lysine: A selective inhibitor of inducible nitric oxide synthase. J. Med. Chem. 37:1994;3886-3888.
54. Morizane C., Adachi K., Furutani I., Fujita Y., Akaike A., Kashii S., Honda Y. N-omega-nitro-l-arginine methyl ester protects retinal neurons against N-methyl-d-aspartate-induced neurotoxicity in vivo. Eur. J. Pharmacol. 328:1997;45-49.
55. Murphy S., Simmons M. L., Agullo L., Garcia A., Feinstein D. L., Galea E., Reis D. J., Minc-Golomb D., Schwartz J. P. Synthesis of nitric oxide in CNS glial cells. Trends Neurosci. 16:1993;323-328.
56. Ochs S., Pourmand R., Jersild R. A. Jr. Origin of beading constrictions at the axolemma: Presence in unmyelinated axons and after beta,beta′-iminodipropionitrile degradation of the cytoskeleton. Neuroscience. 70:1996;1081-1096.
57. Paakkari I., Lindsberg P. Nitric oxide in the central nervous system. Ann. Med. 27:1995;369-377.
58. Peinado-Ramon P., Salvador M., Villegas-Perez M. P., Vidal-Sanz M. Effects of axotomy and intraocular administration of NT-4, NT-3, and brain-derived neurotrophic factor on the survival of adult retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 37:1996;489-500.
59. Pusztai L., Clover L. M., Cooper K., Starkey P. M., Lewis C. E., McGee J. O. Expression of tumor necrosis factor alpha and its receptors in carcinoma of the breast. Br. J. Cancer. 70:1994;289-292.
60. Samdani A. F., Newcamp C., Resink A., Facchinetti F., Hoffman B. E., Dawson V. L., Dawson T. M. Differential susceptibility to neurotoxicity mediated by neurotrophins and neuronal nitric oxide synthase. J. Neurosci. 17:1997;4633-4641.
61. Saxon D. W., Beitz A. J. Cerebellar injury induces NOS in purkinje cells and cerebellar afferent neurons. NeuroReport. 5:1994;809-812.
62. Schmidt W., Wolf G., Calka J., Schmidt H. H. Evidence for bidirectional changes in nitric oxide synthase activity in the rat striatum after excitotoxically quinolinic acid-induced degeneration. Neuroscience. 67:1995;345-356.
63. Schulz J. B., Matthews R. T., Beal M. F. Role of nitric oxide in neurodegenerative diseases. Curr. Opin. Neurol. 8:1995;480-486.
64. Snyder S. H. Nitric oxide: First in a new class of neurotransmitters. Science. 257:1992;494-496.
65. Taupenot L., Ciesielski-Treska J., Ulrich G., Chasserot-Golaz S., Aunis D., Bader M. F. Chromogranin A triggers a phenotypic transformation and the generation of nitric oxide in brain microglial cells. Neuroscience. 72:1996;377-389.
66. Taupin V., Renno T., Bourbonniere L., Peterson A. C., Rodriguez M., Owens T. Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system. Eur. J. Immunol. 27:1997;905-913.
67. Tran E. H., Hardin-Pouzet H., Verge G., Owens T. Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 74:1997;121-129.
68. Van Muiswinkel F. L., Veerhuis R., Eikelenboom P. Amyloid beta protein primes cultured rat microglial cells for enhanced phorbol 12-myristate 13-acetate-induced respiratory burst activity. J. Neurochem. 66:1996;2468-2476.
69. Vidal-Sanz M., Bray G. M., Villegas-Perez M. P., Thanos S., Aguayo A. J. Axonal regeneration and synapse formation in the superior colliculus by retinal ganglion cells in the adult rat. J. Neurosci. 7:1987;2897-2909.
70. Villegas-Perez M. P., Vidal-Sanz M., Bray G. M., Aguayo A. J. Influences of peripheral nerve grafts on the survival and regrowth of axotomized retinal ganglion cells in adult rats. J. Neurosci. 8:1988;265-280.
71. Vodovotz Y., Lucia M. S., Flanders K. C., Chesler L., Xie Q. W., Smith T. W., Weidner J., Mumford R., Webber R., Nathan C., Roberts A. B., Lippa C. F., Sporn M. B. Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J. Exp. Med. 184:1996;1425-1433.
72. Vorwerk C. K., Hyman B. T., Miller J. W., Husain D., Zurakowski D., Huang P. L., Fishman M. C., Dreyer E. B. The role of neuronal and endothelial nitric oxide synthase in retinal excitoxicity. Invest. Ophthalmol. Vis. Sci. 38:1997;2038-2044.
73. Wallace M. N., Bisland S. K. NADPH-diaphorase activity in activated astrocytes represents inducible nitric oxide synthase. Neuroscience. 59:1994;905-919.
74. Weldon D. T., Rogers S. D., Ghilardi J. R., Finke M. P., Cleary J. P., O'Hare E., Esler W. P., Maggio J. E., Mantyh P. W. Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J. Neurosci. 18:1998;2161-2173.
75. Yamamoto R., Bredt D. S., Dawson T. M., Snyder S. H., Stone R. A. Enhanced expression of nitric oxide synthase by rat retina following pterygopalatine parasympathetic denervation. Brain Res. 631:1993;83-88.
76. G-hydroxy-l-arginine by cultured endothelial cells. Proc. Natl. Acad. Sci. USA. 88:1991;11172-11176.
77. Zemel E., Eyal O., Lei B., Perlman I. NADPH diaphorase activity in mammalian retinas is modulated by the state of visual adaptation. Vis. Neurosci. 13:1996;863-871.